Unknown

Dataset Information

0

A Randomized Controlled Trial to Evaluate if Computerized Cognitive Rehabilitation Improves Neurocognition in Ugandan Children with HIV.


ABSTRACT: OBJECTIVES:Clinically stable children with HIV can have neuromotor, attention, memory, visual-spatial, and executive function impairments. We evaluated neuropsychological and behavioral benefits of computerized cognitive rehabilitation training (CCRT) in Ugandan HIV children. DESIGN:One hundred fifty-nine rural Ugandan children with WHO Stage I or II HIV disease (6 to 12 years; 77 boys, 82 girls; M = 8.9, SD = 1.86 years) were randomized to one of three treatment arms over a 2-month period. METHODS:The CCRT arm received 24 one-hour sessions over 2 months, using Captain's Log (BrainTrain Corporation) programmed for games targeting working memory, attention, and visual-spatial analysis. These games progressed in difficulty as the child's performance improved. The second arm was a "limited CCRT" with the same games rotated randomly from simple to moderate levels of training. The third arm was a passive control group receiving no training. All children were assessed at enrollment, 2 months (immediately following CCRT), and 3 months after CCRT completion. RESULTS:The CCRT group had significantly greater gains through 3 months of follow-up compared to passive controls on overall Kaufman Assessment Battery for Children-second edition (KABC-II) mental processing index (p < .01), planning (p = .04), and knowledge (p = .03). The limited CCRT group performed better than controls on learning (p = .05). Both CCRT arms had significant improvements on CogState Groton maze learning (p < .01); although not on CogState attention/memory, TOVA/impulsivity, or behavior rating inventory for executive function and child behavior checklist (psychiatric behavior/symptom problems) ratings by caregiver. CONCLUSIONS:CCRT intervention can be effective for neurocognitive rehabilitation in children with HIV in low-resource settings, especially in children who are clinically stable on ARV treatment.

SUBMITTER: Boivin MJ 

PROVIDER: S-EPMC4971428 | BioStudies | 2016-01-01

SECONDARY ACCESSION(S): NCT00926003

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6127009 | BioStudies
2013-01-01 | S-EPMC3812379 | BioStudies
2017-01-01 | S-EPMC5654614 | BioStudies
2019-01-01 | S-EPMC6629482 | BioStudies
2008-01-01 | S-EPMC2721476 | BioStudies
2017-01-01 | S-EPMC5654157 | BioStudies
1000-01-01 | S-EPMC5517521 | BioStudies
2008-01-01 | S-EPMC2587235 | BioStudies
2018-01-01 | S-EPMC6226335 | BioStudies
2014-01-01 | S-EPMC3999287 | BioStudies